Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CFO Sells $86,154.74 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CFO Alexis Desieno sold 25,118 shares of the business’s stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $3.43, for a total transaction of $86,154.74. Following the completion of the transaction, the chief financial officer now owns 116,481 shares of the company’s stock, valued at $399,529.83. This represents a 17.74 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Alexis Desieno also recently made the following trade(s):

• On Wednesday, October 2nd, Alexis Desieno sold 7,487 shares of Cardlytics stock. The stock was sold at an average price of $3.08, for a total transaction of $23,059.96.

Cardlytics Stock Performance

Shares of CDLX stock traded down $0.22 during trading hours on Friday, hitting $3.38. 1,038,456 shares of the company’s stock were exchanged, compared to its average volume of 1,235,099. The firm has a 50 day moving average of $3.73 and a two-hundred day moving average of $6.48. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. Cardlytics, Inc. has a fifty-two week low of $2.89 and a fifty-two week high of $20.52.

Cardlytics (NASDAQ:CDLX) last released its earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.33) by $0.18. The business had revenue of $67.06 million for the quarter, compared to the consensus estimate of $57.77 million. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The business’s quarterly revenue was down 15.1% compared to the same quarter last year. During the same quarter last year, the business posted ($0.26) earnings per share. On average, equities research analysts predict that Cardlytics, Inc. will post -1.72 EPS for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

Hedge funds have recently modified their holdings of the company. Atom Investors LP purchased a new position in Cardlytics during the third quarter worth about $33,000. Canton Hathaway LLC raised its holdings in shares of Cardlytics by 95.7% in the 2nd quarter. Canton Hathaway LLC now owns 4,500 shares of the company’s stock valued at $37,000 after buying an additional 2,200 shares during the period. SG Americas Securities LLC purchased a new stake in Cardlytics during the third quarter worth about $45,000. Intech Investment Management LLC purchased a new stake in Cardlytics during the 3rd quarter worth approximately $47,000. Finally, Quadrature Capital Ltd acquired a new position in shares of Cardlytics in the third quarter worth $63,000. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Wall Street Analyst Weigh In

CDLX has been the subject of a number of recent analyst reports. Bank of America cut Cardlytics from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $4.00 to $3.50 in a research report on Thursday, August 15th. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Thursday, November 7th. Lake Street Capital lowered shares of Cardlytics from a “buy” rating to a “hold” rating and cut their price objective for the stock from $18.00 to $5.00 in a research note on Thursday, August 8th. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. Finally, Evercore ISI started coverage on Cardlytics in a research note on Friday, October 11th. They set an “in-line” rating and a $4.00 price objective for the company. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $6.92.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.